Literature DB >> 17652473

Catheter-related fungemia due to fluconazole-resistant Candida nivariensis.

Shin-ichi Fujita1, Yasuko Senda, Tikako Okusi, Yumi Ota, Hideaki Takada, Kazunori Yamada, Mitsuhiro Kawano.   

Abstract

We report on a case of fungemia due to fluconazole-resistant Candida nivariensis (MIC, > or =128 microg/ml). Internal transcribed spacer PCR followed by microchip gel electrophoresis with a blood culture that tested positive revealed a unique pattern different from those of other pathogenic yeasts.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17652473      PMCID： PMC2045379          DOI： 10.1128/JCM.00727-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  6 in total

1.  Multiplex PCR using internal transcribed spacer 1 and 2 regions for rapid detection and identification of yeast strains.

Authors:  S I Fujita; Y Senda; S Nakaguchi; T Hashimoto
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

2.  Guidelines for treatment of candidiasis.

Authors:  Peter G Pappas; John H Rex; Jack D Sobel; Scott G Filler; William E Dismukes; Thomas J Walsh; John E Edwards
Journal:  Clin Infect Dis       Date:  2003-12-19       Impact factor: 9.079

3.  Phenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungus.

Authors:  Julia Alcoba-Flórez; Sebastián Méndez-Alvarez; Josep Cano; Josep Guarro; Eduardo Pérez-Roth; María del Pilar Arévalo
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

4.  PCR protocol for specific identification of Candida nivariensis, a recently described pathogenic yeast.

Authors:  Julia Alcoba-Flórez; María del Pilar Arévalo; F Javier González-Paredes; Josep Cano; Josep Guarro; Eduardo Pérez-Roth; Sebastián Méndez-Alvarez
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

5.  Rapid identification of staphylococcal strains from positive-testing blood culture bottles by internal transcribed spacer PCR followed by microchip gel electrophoresis.

Authors:  Shin-Ichi Fujita; Yasuko Senda; Thikako Iwagami; Takuma Hashimoto
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

6.  Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testing.

Authors:  M A Pfaller; S Arikan; M Lozano-Chiu; Y Chen; S Coffman; S A Messer; R Rennie; C Sand; T Heffner; J H Rex; J Wang; N Yamane
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948
  6 in total
  21 in total

Review 1.  Candida nivariensis as a New Emergent Agent of Vulvovaginal Candidiasis: Description of Cases and Review of Published Studies.

Authors:  Pilar Aznar-Marin; Fátima Galan-Sanchez; Pilar Marin-Casanova; Pedro García-Martos; Manuel Rodríguez-Iglesias
Journal:  Mycopathologia       Date:  2015-12-26       Impact factor: 2.574

2.  Caenorhabditis elegans as a Model System To Assess Candida glabrata, Candida nivariensis, and Candida bracarensis Virulence and Antifungal Efficacy.

Authors:  Ainara Hernando-Ortiz; Estibaliz Mateo; Marcelo Ortega-Riveros; Iker De-la-Pinta; Guillermo Quindós; Elena Eraso
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

3.  Candida nivariensis isolated from an Indonesian human immunodeficiency virus-infected patient suffering from oropharyngeal candidiasis.

Authors:  Retno Wahyuningsih; Ivo N SahBandar; Bart Theelen; Ferry Hagen; Gé Poot; Jacques F Meis; Anna Rozalyani; Ridhawati Sjam; Djoko Widodo; Samsuridjal Djauzi; Teun Boekhout
Journal:  J Clin Microbiol       Date:  2007-11-14       Impact factor: 5.948

4.  Occurrence and characterization of Candida nivariensis from a culture collection of Candida glabrata clinical isolates in Malaysia.

Authors:  Sun Tee Tay; Azadeh Lotfalikhani; Negar Shafiei Sabet; Sasheela Ponnampalavanar; Sofiah Sulaiman; Shiang Ling Na; Kee Peng Ng
Journal:  Mycopathologia       Date:  2014-07-15       Impact factor: 2.574

5.  Rapid discrimination between Candida glabrata, Candida nivariensis, and Candida bracarensis by use of a singleplex PCR.

Authors:  A Enache-Angoulvant; J Guitard; F Grenouillet; T Martin; P Durrens; C Fairhead; C Hennequin
Journal:  J Clin Microbiol       Date:  2011-07-13       Impact factor: 5.948

6.  Prevalence of Candida nivariensis and Candida bracarensis in vulvovaginal Candidiasis.

Authors:  Jianling Li; Yingying Shan; Shangrong Fan; Xiaoping Liu
Journal:  Mycopathologia       Date:  2014-08-15       Impact factor: 2.574

7.  Differentiation of Candida glabrata, C. nivariensis and C. bracarensis based on fragment length polymorphism of ITS1 and ITS2 and restriction fragment length polymorphism of ITS and D1/D2 regions in rDNA.

Authors:  H Mirhendi; B Bruun; H C Schønheyder; J J Christensen; K Fuursted; B Gahrn-Hansen; H K Johansen; L Nielsen; J D Knudsen; M C Arendrup
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-24       Impact factor: 3.267

8.  Molecular identification of closely related Candida species using two ribosomal intergenic spacer fingerprinting methods.

Authors:  Muriel Cornet; Boualem Sendid; Chantal Fradin; Claude Gaillardin; Daniel Poulain; Huu-Vang Nguyen
Journal:  J Mol Diagn       Date:  2010-12-23       Impact factor: 5.568

9.  Molecular Identification of Candida Species Isolated from Onychomycosis in Shanghai, China.

Authors:  Xiaobo Feng; Bo Ling; Xianwei Yang; Wanqing Liao; Weihua Pan; Zhirong Yao
Journal:  Mycopathologia       Date:  2015-07-31       Impact factor: 2.574

10.  Candida bracarensis detected among isolates of Candida glabrata by peptide nucleic acid fluorescence in situ hybridization: susceptibility data and documentation of presumed infection.

Authors:  Justin A Bishop; Nancy Chase; Shelley S Magill; Cletus P Kurtzman; Mark J Fiandaca; William G Merz
Journal:  J Clin Microbiol       Date:  2007-12-12       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.